# Broken String Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/broken-string-biosciences

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Total disclosed funding: $19M
- Latest round: Series A (Sep 18, 2023)
- Investors on record: 6

## About

Based in Cambridge, UK, and co-founded by Felix Dobbs (CEO), Simon Reed (CSO), Simon Kerr (Chairperson), and Patrick Van (Senior Scientist) in 2020, Broken String Biosciences Limited operates as a biotechnology company offering a sequencing platform for cell and gene therapies. In September 2023, the firm raised USD 15 million in series A funding co-led by investors Illumina Ventures and Merieux Equity Partners, with participation from other investors HERAN Partners, Dieter von Holtzbrinck Ventures, and Tencent.

The company provides a sequencing platform that combines biology, sequencing techniques, bioinformatics, data science, and artificial intelligence to develop genome editing methods, resulting in more efficient and cost-effective cell and gene therapies. Broken String’s core technology is INDUCE-seq™, a DNA break mapping technology that precisely analyzes how genome editors interact with and modify genomes. This technique equips researchers and developers by offering critical insights into genome editing processes, resulting in more efficient and targeted therapeutic development.

The company plans to utilize the September 2023 funding to develop its Next Generation Sequencing-based DNA break mapping platform, expand its capabilities beyond gene editing, develop its strategy, and establish commercial traction.

## Funding rounds

- Series A, Sep 18, 2023, $15M — Merieux Equity Partners, Dieter von Holtzbrinck Ventures, Illumina Ventures, HERAN Partners, Tencent Investment
- Seed, Sep 7, 2021, $4.2M — Dieter von Holtzbrinck Ventures, Time Partners, Tencent Investment

## Investors

- Dieter von Holtzbrinck Ventures (https://capitalatlas.ai/funds/dieter-von-holtzbrinck-ventures) — Seed, Series A
- Time Partners (https://capitalatlas.ai/funds/time-partners) — Seed
- Tencent Investment — Seed, Series A
- Merieux Equity Partners (https://capitalatlas.ai/funds/merieux-equity-partners) — Series A
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Series A
- HERAN Partners (https://capitalatlas.ai/funds/heran-partners) — Series A